494 OR502, a best-in-class anti-LILRB2 antibody that enhances both innate and adaptive anti-tumor immune responses

• Peter Probst,
• Kevin Green,
• Huyen Dinh,
• Francisco Zapata,
• Darbie Whitman,
• Tom Graddis,
• Meghan Zuck,
• Ray Fox,
• Myriam N Bouchlaka,
• Tatyana Pisarenko,
• Elsa L Hay,
• Gajendra Naika,
• Jacob Heit,
• Kamal D Puri

Affiliations

Peter Probst

OncResponse Inc., Seattle, WA, USA

Kevin Green

OncResponse Inc., Seattle, WA, USA

Huyen Dinh

OncResponse Inc., Seattle, WA, USA

Francisco Zapata

OncResponse Inc., Seattle, WA, USA

Darbie Whitman

OncResponse Inc., Seattle, WA, USA

Tom Graddis

OncResponse Inc., Seattle, WA, USA

Meghan Zuck

OncResponse Inc., Seattle, WA, USA

Ray Fox

OncResponse Inc., Seattle, WA, USA

Myriam N Bouchlaka

OncResponse Inc., Seattle, WA, USA

Tatyana Pisarenko

OncResponse Inc., Seattle, WA, USA

Elsa L Hay

OncResponse Inc., Seattle, WA, USA

Gajendra Naika

OncResponse Inc., Seattle, WA, USA

Jacob Heit

OncResponse Inc., Seattle, WA, USA

Kamal D Puri

OncResponse Inc., Seattle, WA, USA